AuraTracer智迹闻
中文

EVENT DOSSIER

“Brain-computer interface headquarters +1! Xiamang Medical has established its operations in Chengdu High-tech Zone”

2026-09-08 01:17 Products & Apps 🔥 40.2 heat score
1sources
1days unfolding
40.2heat score
5mentions
SummaryAI generated

On September 7, 2026, according to a report by Southern Weekend, Brain-Computer Interface company Ximang Medical officially established its headquarters in Chengdu High-Tech Zone. This development is seen as an important progress for Ximang Medical in the field of brain-computer interfaces, indicating that its headquarters or core research and development base has been set up in Chengdu High-Tech Zone.

Related eventsRELATED EVENTS
Key entitiesKEY ENTITIES
Chengdu High-Tech ZoneGestalt TechnologyHuaxi HospitalSichuan Provincial People's HospitalXi Mang Medical

Coverage · reports per dayLANGUAGE SPLIT

Entity relations
Chengdu High-Tech Zone …1Chengdu High-Tech Zone …1Chengdu High-Tech Zone …1Chengdu High-Tech Zone …1Gestalt Technology × Hu…1Gestalt Technology × Si…1

SignalsSIGNALS

Keyword heat
  • Xi Mang Medical1
  • Chengdu High-Tech Zone1
  • Huaxi Hospital1
  • Sichuan Provincial People's Hospital1
  • Gestalt Technology1

All reports (1)SOURCES

南方周末 zh 2026-09-08 01:17

“Brain-computer interface headquarters +1! Xiamang Medical has set up its operations in Chengdu High-Tech Zone”

Chengdu Ximan Medical Technology Co., Ltd. has officially established its headquarters in Chengdu High-Tech Zone, with plans to invest in building a headquarters and a research and development production base for implantable brain-computer interfaces in the region. The project includes components such as the corporate headquarters, research and development center, manufacturing center, and market operation center. Its aim is to leverage clinical resources from West China Hospital and other institutions to establish a research and development and clinical transformation platform for implantable brain-computer interface medical devices. Ximan Medical specializes in the research and development of flexible neural electrodes, dedicated brain-computer chips, and neural regulation implantation systems, possessing multiple core technologies and independent intellectual property rights. The company has already completed financing of tens of millions of yuan. It plans to adopt a dual-development strategy, targeting the clinical market with products such as digital electroencephalographs and implantable rehabilitation systems for impaired consciousness, and the scientific research market with the μNeurode series of microelectrodes and dedicated ASIC chips. Chengdu High-Tech Zone has already made early investments in the field of brain-computer interfaces. The global headquarters and super factory of Formatta Technology have been built and put into operation, and they are accelerating the mass production and launch of next-generation implantable neural medical devices.